Breaking News, Promotions & Moves

Lonza CEO to Retire, Successor Announced

Richard Ridinger is retiring after seven years as CEO, and current COO, Marc Funk, will take the position effective March 1, 2019.

Lonza announced that Richard Ridinger, current chief executive officer, has decided to retire from the company after seven successful years. Going forward, he intends to build a portfolio of non-executive positions in various companies. His successor as chief executive officer as of 1 March 2019 will be Marc Funk, currently chief operating officer of the Pharma & Biotech division.To ensure a seamless transition of leadership, Richard Ridinger will remain with the company until the end of ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters